Cargando…
Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model
The management of neuropathic pain is still a major challenge because of its unresponsiveness to most common treatments. Curcumin has been reported to play an active role in the treatment of various neurological disorders, such as neuropathic pain. Curcumin has long been recognized as a p300/CREB-bi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946321/ https://www.ncbi.nlm.nih.gov/pubmed/24603592 http://dx.doi.org/10.1371/journal.pone.0091303 |
_version_ | 1782306635295752192 |
---|---|
author | Zhu, Xiaoyan Li, Qian Chang, Ruimin Yang, Dong Song, Zongbing Guo, Qulian Huang, Changsheng |
author_facet | Zhu, Xiaoyan Li, Qian Chang, Ruimin Yang, Dong Song, Zongbing Guo, Qulian Huang, Changsheng |
author_sort | Zhu, Xiaoyan |
collection | PubMed |
description | The management of neuropathic pain is still a major challenge because of its unresponsiveness to most common treatments. Curcumin has been reported to play an active role in the treatment of various neurological disorders, such as neuropathic pain. Curcumin has long been recognized as a p300/CREB-binding protein (CBP) inhibitor of histone acetyltransferase (HAT) activity. However, this mechanism has never been investigated for the treatment of neuropathic pain with curcumin. The aim of the present study was to investigate the anti-nociceptive role of curcumin in the chronic constriction injury (CCI) rat model of neuropathic pain. Furthermore, with this model we investigated the effect of curcumin on P300/CBP HAT activity-regulated release of the pro-nociceptive molecules, brain-derived neurotrophic factor (BDNF) and cyclooxygenase-2 (Cox-2). Treatment with 40 and 60 mg/kg body weight curcumin for 7 consecutive days significantly attenuated CCI-induced thermal hyperalgesia and mechanical allodynia, whereas 20 mg/kg curcumin showed no significant analgesic effect. Chromatin immunoprecipitation analysis revealed that curcumin dose-dependently reduced the recruitment of p300/CBP and acetyl-Histone H3/acetyl-Histone H4 to the promoter of BDNF and Cox-2 genes. A similar dose-dependent decrease of BDNF and Cox-2 in the spinal cord was also observed after curcumin treatment. These results indicated that curcumin exerted a therapeutic role in neuropathic pain by down-regulating p300/CBP HAT activity-mediated gene expression of BDNF and Cox-2. |
format | Online Article Text |
id | pubmed-3946321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39463212014-03-12 Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model Zhu, Xiaoyan Li, Qian Chang, Ruimin Yang, Dong Song, Zongbing Guo, Qulian Huang, Changsheng PLoS One Research Article The management of neuropathic pain is still a major challenge because of its unresponsiveness to most common treatments. Curcumin has been reported to play an active role in the treatment of various neurological disorders, such as neuropathic pain. Curcumin has long been recognized as a p300/CREB-binding protein (CBP) inhibitor of histone acetyltransferase (HAT) activity. However, this mechanism has never been investigated for the treatment of neuropathic pain with curcumin. The aim of the present study was to investigate the anti-nociceptive role of curcumin in the chronic constriction injury (CCI) rat model of neuropathic pain. Furthermore, with this model we investigated the effect of curcumin on P300/CBP HAT activity-regulated release of the pro-nociceptive molecules, brain-derived neurotrophic factor (BDNF) and cyclooxygenase-2 (Cox-2). Treatment with 40 and 60 mg/kg body weight curcumin for 7 consecutive days significantly attenuated CCI-induced thermal hyperalgesia and mechanical allodynia, whereas 20 mg/kg curcumin showed no significant analgesic effect. Chromatin immunoprecipitation analysis revealed that curcumin dose-dependently reduced the recruitment of p300/CBP and acetyl-Histone H3/acetyl-Histone H4 to the promoter of BDNF and Cox-2 genes. A similar dose-dependent decrease of BDNF and Cox-2 in the spinal cord was also observed after curcumin treatment. These results indicated that curcumin exerted a therapeutic role in neuropathic pain by down-regulating p300/CBP HAT activity-mediated gene expression of BDNF and Cox-2. Public Library of Science 2014-03-06 /pmc/articles/PMC3946321/ /pubmed/24603592 http://dx.doi.org/10.1371/journal.pone.0091303 Text en © 2014 Zhu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Zhu, Xiaoyan Li, Qian Chang, Ruimin Yang, Dong Song, Zongbing Guo, Qulian Huang, Changsheng Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model |
title | Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model |
title_full | Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model |
title_fullStr | Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model |
title_full_unstemmed | Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model |
title_short | Curcumin Alleviates Neuropathic Pain by Inhibiting p300/CBP Histone Acetyltransferase Activity-Regulated Expression of BDNF and Cox-2 in a Rat Model |
title_sort | curcumin alleviates neuropathic pain by inhibiting p300/cbp histone acetyltransferase activity-regulated expression of bdnf and cox-2 in a rat model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946321/ https://www.ncbi.nlm.nih.gov/pubmed/24603592 http://dx.doi.org/10.1371/journal.pone.0091303 |
work_keys_str_mv | AT zhuxiaoyan curcuminalleviatesneuropathicpainbyinhibitingp300cbphistoneacetyltransferaseactivityregulatedexpressionofbdnfandcox2inaratmodel AT liqian curcuminalleviatesneuropathicpainbyinhibitingp300cbphistoneacetyltransferaseactivityregulatedexpressionofbdnfandcox2inaratmodel AT changruimin curcuminalleviatesneuropathicpainbyinhibitingp300cbphistoneacetyltransferaseactivityregulatedexpressionofbdnfandcox2inaratmodel AT yangdong curcuminalleviatesneuropathicpainbyinhibitingp300cbphistoneacetyltransferaseactivityregulatedexpressionofbdnfandcox2inaratmodel AT songzongbing curcuminalleviatesneuropathicpainbyinhibitingp300cbphistoneacetyltransferaseactivityregulatedexpressionofbdnfandcox2inaratmodel AT guoqulian curcuminalleviatesneuropathicpainbyinhibitingp300cbphistoneacetyltransferaseactivityregulatedexpressionofbdnfandcox2inaratmodel AT huangchangsheng curcuminalleviatesneuropathicpainbyinhibitingp300cbphistoneacetyltransferaseactivityregulatedexpressionofbdnfandcox2inaratmodel |